drugs
Business
OpenAI and the FDA Are Holding Talks About Using AI In Drug Evaluation
By Zoë Schiffer, Emily Mullin, and Will Knight
Business
The Ketamine-Fueled ‘Psychedelic Slumber Parties’ That Get Tech Execs Back on Track
By Elana Klein
Science
A Popular Decongestant Doesn’t Work. The FDA Is Finally Doing Something About It
By Beth Mole, Ars Technica
Politics
JD Vance’s Senate Office Fires Key Adviser Who Posted About Drug Use on Reddit
By Makena Kelly
Science
The Maker of Ozempic Is Trying to Block Compounded Versions of Its Blockbuster Drug
By Kate Knibbs and Emily Mullin
The Big Story
After Shark Tank, Mark Cuban Just Wants to Break Shit—Especially the Prescription Drug Industry
By Lauren Goode